Burling Wealth Partners LLC Purchases New Shares in Mettler-Toledo International Inc. (NYSE:MTD)

Burling Wealth Partners LLC bought a new position in shares of Mettler-Toledo International Inc. (NYSE:MTD - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 380 shares of the medical instruments supplier's stock, valued at approximately $465,000.

Several other institutional investors also recently bought and sold shares of MTD. Farther Finance Advisors LLC lifted its holdings in shares of Mettler-Toledo International by 14.3% during the 4th quarter. Farther Finance Advisors LLC now owns 64 shares of the medical instruments supplier's stock valued at $78,000 after buying an additional 8 shares during the last quarter. M3 Advisory Group LLC boosted its position in shares of Mettler-Toledo International by 5.8% in the fourth quarter. M3 Advisory Group LLC now owns 165 shares of the medical instruments supplier's stock valued at $202,000 after acquiring an additional 9 shares during the period. Apollon Wealth Management LLC grew its position in Mettler-Toledo International by 2.5% in the 4th quarter. Apollon Wealth Management LLC now owns 368 shares of the medical instruments supplier's stock worth $451,000 after purchasing an additional 9 shares during the last quarter. Steward Partners Investment Advisory LLC increased its stake in Mettler-Toledo International by 3.0% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 306 shares of the medical instruments supplier's stock valued at $374,000 after acquiring an additional 9 shares during the period. Finally, Atlantic Union Bankshares Corp lifted its position in Mettler-Toledo International by 0.5% in the fourth quarter. Atlantic Union Bankshares Corp now owns 2,083 shares of the medical instruments supplier's stock worth $2,549,000 after purchasing an additional 10 shares during the period. 95.07% of the stock is currently owned by hedge funds and other institutional investors.

Mettler-Toledo International Stock Performance

Shares of NYSE MTD traded down $8.63 during midday trading on Wednesday, reaching $1,056.60. The stock had a trading volume of 36,853 shares, compared to its average volume of 143,557. The firm has a market cap of $22.02 billion, a price-to-earnings ratio of 26.07, a price-to-earnings-growth ratio of 3.30 and a beta of 1.28. Mettler-Toledo International Inc. has a twelve month low of $946.69 and a twelve month high of $1,546.93. The company's 50 day moving average price is $1,150.43 and its 200 day moving average price is $1,239.91.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its quarterly earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. Equities analysts forecast that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current fiscal year.

Insider Buying and Selling at Mettler-Toledo International

In other Mettler-Toledo International news, insider Christian Magloth sold 790 shares of the company's stock in a transaction on Monday, February 24th. The stock was sold at an average price of $1,313.69, for a total value of $1,037,815.10. Following the completion of the transaction, the insider now owns 734 shares in the company, valued at $964,248.46. This represents a 51.84 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Gerry Keller sold 600 shares of the business's stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $1,351.34, for a total transaction of $810,804.00. Following the completion of the transaction, the insider now directly owns 6 shares in the company, valued at $8,108.04. This trade represents a 99.01 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.94% of the company's stock.

Analyst Upgrades and Downgrades

MTD has been the subject of several analyst reports. Robert W. Baird cut their target price on Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating for the company in a research report on Tuesday, April 22nd. Citigroup upgraded Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 target price on the stock in a report on Monday, April 7th. Evercore ISI lifted their price target on shares of Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an "outperform" rating in a research note on Monday, February 10th. Finally, Wells Fargo & Company lowered their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,125.00 and set an "equal weight" rating on the stock in a report on Thursday, April 17th. One analyst has rated the stock with a sell rating, five have issued a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $1,304.25.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.